Were you looking for information on Gleevec? Gleevek is a common misspelling of Gleevec.
The U.S. Food and Drug Administration has approved Gleevec® (imatinib mesylate) for the treatment of certain types of cancer, including:
  • Leukemia and other cancers of the blood and bone marrow
  • Gastrointestinal stromal tumors (GIST, a cancer of the digestive tract)
  • A rare type of skin cancer known as dermatofibrosarcoma protuberans.
This chemotherapy drug is a tyrosine kinase inhibitor, which means it works by blocking a specific enzyme cancer cells need to grow and multiply. It comes in tablet form and is usually taken once or twice a day.
(Click Gleevec for more information, including possible side effects, generic availability, and some of the factors that can affect your particular dose. You can also click any of the links in the box to the right for specific information.)
5 Easy Tips to Manage Visitors During Cancer Treatment
Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2020 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.